⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAGX News
Jaguar Health, Inc.
Martinrea International Inc. Reports First Quarter Results and Declares Dividend
globenewswire.com
GM
F
VOW3.DE
MBG.DE
JAGX
TSLA
NVDA
GOOG
AMZN
MSFT
Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
accessnewswire.com
JAGX
Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
accessnewswire.com
JAGX
Form 8-K
sec.gov
JAGX
Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
accessnewswire.com
JAGX
Europe’s Largest dedicated Google First Partner Rebrands to Beyond, Redefining a ‘New Era’ in Accelerated AI-Driven Cloud Transformations
globenewswire.com
GOOGL
PAY
JAGX
Xsolla bringt mit Xsolla Agency Zugänglichkeit, soziale Wirkung und die Lizenzierung von Unterhaltungs-IP zum London Games Festival 2026
businesswire.com
LEGO
UBS
JAGX
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
accessnewswire.com
JAGX